Metabolic Analysis of DFO-Resistant Huh7 Cells and Identification of Targets for Combination Therapy
Hepatocellular carcinoma (HCC) is one of the most refractory cancers with a high rate of recurrence. Iron is an essential trace element, and iron chelation has garnered attention as a novel therapeutic strategy for cancer. Since intracellular metabolism is significantly altered by inhibiting various...
Main Authors: | Koichi Fujisawa, Toshihiko Matsumoto, Naoki Yamamoto, Takahiro Yamasaki, Taro Takami |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/10/1073 |
Similar Items
-
Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity
by: Javier Mora, et al.
Published: (2019-05-01) -
Deferiprone–resveratrol hybrid attenuates iron accumulation, oxidative stress, and antioxidant defenses in iron-loaded human Huh7 hepatic cells
by: Jin Li, et al.
Published: (2024-03-01) -
Evaluation of the effects of ascorbic acid on metabolism of human mesenchymal stem cells
by: Koichi Fujisawa, et al.
Published: (2018-04-01) -
Adenylate Kinase Isozyme 3 Regulates Mitochondrial Energy Metabolism and Knockout Alters HeLa Cell Metabolism
by: Koichi Fujisawa, et al.
Published: (2022-04-01) -
Formulation and In-Vitro Characterization of Chitosan-Nanoparticles Loaded with the Iron Chelator Deferoxamine Mesylate (DFO)
by: Maria Lazaridou, et al.
Published: (2020-03-01)